Search results for “Anti-Mesothelin Antibody” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 205 patents, we discovered top 25 key players by total patent application. Mogam Institute For Biomedical Research, Green Cross Corp., Genentech, Inc. are dominant in this area. They take 38.54% of the total patent filing.
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 28
Green Cross Corp.
South Korea
Patent: 26
Genentech, Inc.
California, United States
Patent: 25
Bristol Myers Squibb Co.
New York, United States
Patent: 23
Bayer Intellectual Property GmbH
Nordrhein-Westfalen, Germany
Patent: 21
Eisai, Inc.
New Jersey, United States
Patent: 12
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 10
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 7
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
STARTUP
Anwita Biosciences, Inc.
California, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 89 patents applied in the last 5 years. We discover 19 most active companies in this area. The fast-growing Mogam Institute For Biomedical Research, Green Cross Corp., Silverback Therapeutics, Inc. take 52.81% of patent filing during this period.
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 18
Green Cross Corp.
South Korea
Patent: 17
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 10
Development Center for Biotechnology
Taiwan Province, China
Patent: 8
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 7
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
Novimmune SA
Genève, Switzerland
Patent: 6
F-star Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
UTC Therapeutics, Inc.
Shanghai Shi, China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 89 patents in last 5 years, we discover 13 new entrants. Silverback Therapeutics, Inc., RemeGen Co., Ltd., Development Center for Biotechnology are the most active new entrants in this area.
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 10
Development Center for Biotechnology
Taiwan Province, China
Patent: 8
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 7
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
Novimmune SA
Genève, Switzerland
Patent: 6
F-star Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
UTC Therapeutics, Inc.
Shanghai Shi, China
Patent: 3
STARTUP
Anwita Biosciences, Inc.
California, United States
Patent: 3
GREEN CROSS CELL Corp.
South Korea
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 37 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Okayama University
Okayama-ken, Japan
Patent: 4
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 1
Université d'Aix-Marseille
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: